Related Experiment Video
Updated: Jul 8, 2026

06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Evidence-based estimation and radiotherapy utilisation rate in Andalusia
J Jaén Olasolo1, E Alonso Redondo, J Expósito Hernández
1Department of Radiation Oncology, Puerta del Mar University Hospital, Cádiz, Spain. javier.jaen.sspa@juntadeandalucia.es
Summary
Radiotherapy treatments (RDT) in Andalusia show increased utilization, reaching 85% of theoretical needs in 2006. However, underutilization persists for lung and head and neck cancers, with significant regional disparities in RDT delivery.
Area of Science:
- Oncology
- Radiotherapy Research
- Healthcare Management
Background:
- Estimating evidence-based radiotherapy needs is crucial for optimal cancer care.
- Understanding the gap between theoretical needs and actual radiotherapy treatment (RDT) delivery is essential for resource allocation.
- Analyzing trends in RDT utilization provides insights into healthcare system performance.
Purpose of the Study:
- To estimate the evidence-based radiotherapy needs in Andalusia.
- To compare these needs with the actual utilization of RDT in 2006.
- To analyze the evolution of RDT use from 2003 to 2006.
Main Methods:
- Quantitative variables were analyzed using Pearson's correlation coefficient.
- Differences between administered/estimated and actual treatments were assessed using the Student's t-distribution.
- Qualitative variables were analyzed using the Chi-squared test (Xi2).
Main Results:
- The evidence-based radiotherapy rate in Andalusia was 55%, with 85% of theoretical treatments administered in 2006.
- Treatment administration varied by cancer type: 107% for gynecological, 100% for breast, 71% for head and neck, and 48% for lung cancer.
- Significant regional differences in irradiation rates (p<0.0002) and resource distribution were observed. Public hospital treatments increased by 17% over three years.
Conclusions:
- Despite increased RDT utilization, significant underuse occurs for lung and head and neck cancers.
- Substantial variability in RDT use exists across different hospitals in Andalusia.
- Further optimization of radiotherapy services is needed to address disparities and ensure equitable access to care.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
